Expert Shares Tips for Talking Sexual Health With Cancer Survivors
September 28th 2016Sexual health can change dramatically after treatment for cancer but it often goes undiscussed. A recent webinar sought to education healthcare practioners in addressed sexual health concerns with their patients.
For Men With Low-Risk Prostate Cancer, Active Surveillance Does Not Cause More Stress
September 27th 2016For men with positive needle biopsy for prostate cancer, active surveillance (AS) did not negatively impact their quality-of-life compared with men who had a negative prostate needle biopsy.
Study Suggests Dermatography May Be Helpful For People With Surgical Scars
September 27th 2016Although dermatography (medical tattooing) is commonly performed around the world as a component of nipple reconstruction after mastectomy, it is rarely used as an adjuvant to enhance the appearance of scars and skin grafts after surgical procedures.
Flashy for a Cause: Raising Awareness for Childhood Cancers
September 20th 2016Chase After a Cure is running a Thunderclap campaign on Sept. 15 and is asking people to be flashy for a good cause: awareness and funds for childhood cancers. - See more at: http://www.curetoday.com/articles/flashy-for-a-cause-raising-awareness-for-childhood-cancers#sthash.uyBvOZyJ.dpuf
Medical Mistrust, Lack of Information, Among Concerns of African American Breast Cancer Survivors
September 12th 2016African American breast cancer survivors experience some specific concerns and risk factors that healthcare practitioners should be aware of when developing survivorship care plans for this population.
Author Reflects on Benefits of Adult Coloring Books After a Cancer Diagnosis
September 6th 2016Deborah Derman used her personal losses and professional experiences to create the new book Colors of Loss and Healing: An Adult Coloring Book for Getting Through Tough Times to help people move forward in their lives.
Blinatumomab Approved for Pediatric Acute Lymphoblastic Leukemia
September 2nd 2016Blinatumomab (Blincyto) gained accelerated approval by the FDA for the treatment of pediatric and adolescent patients with Philadelphia chromosome-negative (Ph-) relapsed or refractory B-cell precursor acute lymphoblastic leukemia (ALL)